Goldman Sachs’s ProPhase Labs PRPH Stock Holding History
Bought
Maintained
Sold
Other funds holding PRPH
PCM
SW
Goldman Sachs's PRPH Position: Q2 2024 in Review
Goldman Sachs sold out of ProPhase Labs (PRPH) in Q2 2024, closing a stake of 2,379 shares — an estimated $154K sold.
Goldman Sachs first reported a position in PRPH in Q3 2014 and held it in 15 quarters. The position peaked at $385K in Q3 2023. 29 funds tracked by Wall St. Rank hold PRPH as of Q2 2024.
- Goldman Sachs reported no remaining ProPhase Labs position as of Q2 2024 after selling out during the quarter.
- Goldman Sachs sold 2,379 ProPhase Labs shares in Q2 2024, an estimated $154K.
- Goldman Sachs first reported a position in ProPhase Labs in Q3 2014 and held it in 15 quarters.
- Goldman Sachs's ProPhase Labs position peaked at $385K in Q3 2023.
- 29 funds tracked by Wall St. Rank held ProPhase Labs as of Q2 2024.
Based on Goldman Sachs's 13F filing for Q2 2024, filed 13 Aug 2024.